Finnish scientists awarded for dog gel paper
A research group led by Finnish Orion Pharma scientists have landed an award for a study paper on dexmedetomidine oromucosal gel for noise anxiety in dogs.
Dr. Mira Korpivaara (DVM) and Dr. Mirja Huhtinen (DVM, PhD) from Orion Pharma Research and Development, together with their collaborators, landed the Veterinary Record Impact Award by the British Veterinary Associations’s renowed weekly journal Veterinary Record.
The award’s purpose is to recognise a research paper published in the journal within the previous 12 months that is considered to have the most potential contribution for changing veterinary practice. The winning paper “Dexmedetomidine oromucosal gel for noise-associated acute anxiety and fear in dogs – a randomised, double-blind, placebo-controlled clinical study” reported the results from a clinical study demonstrating that oromucosal dexmedetomidine gel at subsedative doses alleviates noise-associated acute anxiety and fear in dogs.
According to the reviewers, the paper is “an important contribution to the literature on acute anxiety and fear associated with noise in dogs”.
“We are very excited and proud of the recognition by the Veterinary Record,” says Korpivaara. “There is an unmet need for treatment options for dogs suffering from noise anxiety. Our study demonstrated that dexmedetomidine oromucosal gel provides veterinarians a treatment option for alleviation of acute anxiety and fear associated with noise in dogs.”
Other contributors to the paper were veterinary behaviour specialists Karen Overall (University of Pennsylvania, USA), Barbara Schöning (Veterinary Specialty Practice for Behaviour, Hamburg, Germany) and Kaisa Laapas (Biostatistician).